Nuvation Bio Inc.
NUVBNYSEHealthcare● Active
$4.80
$-0.02(-0.41%)
Market Cap$1.7B
P/E Ratio—
52W High$9.75
52W Low$1.57
Nuvation Bio Inc.（NUVB）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · NUVB · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $62.90M | $7.87M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $8.44M | $7.08M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $54.46M | $0.80M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 86.58% | 10.10% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $115.11M | $524.19M | $71.29M | $87.81M | $69.04M |
| G&A Expenses | $0.00M | $66.73M | $28.53M | $31.92M | $24.28M |
| Total Operating Expenses | $267.52M | $593.42M | $99.82M | $119.73M | $93.32M |
| Operating Income | ($213.06M) | ($592.63M) | ($99.82M) | ($119.73M) | ($93.32M) |
| Operating Margin %(computed) | -338.72% | — | — | — | — |
| Interest Income | $21.43M | $27.06M | $24.61M | $7.45M | $2.96M |
| Interest Expense | $13.68M | $0.34M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($204.63M) | ($567.94M) | ($75.80M) | ($104.20M) | ($86.85M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($204.63M) | ($567.94M) | ($75.80M) | ($104.20M) | ($86.85M) |
| Net Margin %(computed) | -325.31% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.60 | $-2.11 | $-0.35 | $-0.48 | $-0.44 |
| Wtd Avg Shares | 341.54M | 268.77M | 218.88M | 216.72M | 197.89M |
| EBITDA | ($190.94M) | ($566.91M) | ($75.58M) | ($119.53M) | ($93.13M) |
| EBITDA Margin %(computed) | -303.56% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Nuvation Bio Inc.
关于Nuvation Bio Inc.（NUVB）损益表
Nuvation Bio Inc.（NUVB）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，NUVB实现营收$0.06B，毛利润$0.05B（毛利率86.58%），净利润($0.20B)（净利率-325.31%）。
常见问题
NUVB · 4 问Nuvation Bio Inc.（NUVB）2025财年营收为$0.06B，同比up699.0%。
NUVB revenueNUVB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08